Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Whole-genome sequencing analysis reveals new susceptibility loci and structural variants associated with progressive supranuclear palsy

Molecular Neurodegeneration(2024)10.1186/s13024-024-00747-3Source: DataRank Database

Whole-genome sequencing analysis reveals new susceptibility loci and structural variants associated with progressive supranuclear palsy is a research paper published in Molecular Neurodegeneration (2024). On theSindex it has a DataRank of 0.665. It has been cited 26 times, with 18 citing works in its 1-hop citation network.

N/A

0.665DataRank · unranked

Scored on demand from live citation data

Open Access26 citations · 18 citing works in its network

Download PDF

Cite:

Linked data & code

gen refsnp doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (27 grants)Impact (FWCI 7.05)OA: goldTopics (34)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 74%Citation Network 26%

Base Score Contribution

0.494

From this paper's citation signal

Citation Network Contribution

0.171

From 9 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 18 citers.

Investigation of the HLA locus in autopsy-confirmed progressive supranuclear palsy
Immunobiology20255 citations51 referencesContributes 0.035
APOE4 to APOE2 allelic switching in mice improves Alzheimer’s disease-related metabolic signatures, neuropathology and cognition
Nature Neuroscience202510 citations69 referencesContributes 0.035
Tau processing and tau-mediated inflammation differ in human APOEε2 and APOEε4 astrocytes
iScience20243 citations55 referencesContributes 0.025
Current insights into apolipoprotein E and the immune response in Alzheimer's disease
Immunological Reviews202416 citations115 referencesContributes 0.025
The Genetic Background of the Immunological and Inflammatory Aspects of Progressive Supranuclear Palsy
International Journal of Molecular Sciences20253 citations58 referencesContributes 0.024

Authors (62)

Timothy S. Chang ORCID,Beth A. Dombroski ORCID,Po‐Liang Cheng ORCID,Vishakha Patil,Leopoldo Valiente‐Banuet

Live enrichment

PubMed:39152475 PMC:PMC11330058 OpenAlex:https://openalex.org/W4401635449

NIH

Grant: RF1-AG074328

NIH

Grant: 5UG3NS104095

NIA NIH HHS

Grant: P30 AG019610

NIA NIH HHS

Grant: P30 AG062422

NIA NIH HHS

Grant: P30 AG062429

NIA NIH HHS

Grant: P30 AG072980

NIA NIH HHS

Grant: P50 AG016574

NIA NIH HHS

Grant: P01 AG017586

NINDS NIH HHS

Grant: U54 NS100693

NIA NIH HHS

Grant: K08 AG065519

NIA NIH HHS

Grant: R01 AG032990

NIA NIH HHS

Grant: U01 AG006786

NIA NIH HHS

Grant: U54 AG052427

NIA NIH HHS

Grant: RF1 AG074328

NIA NIH HHS

Grant: P30 AG072979

NIA NIH HHS

Grant: P50 AG025711

NINDS NIH HHS

Grant: R01 NS080820

NIA NIH HHS

Grant: U01 AG046139

NIA NIH HHS

Grant: P01 AG003949

NIA NIH HHS

Grant: P01 AG019724

NIA NIH HHS

Grant: P01 AG017216

NINDS NIH HHS

Grant: U24 NS072026

NINDS NIH HHS

Grant: UG3 NS104095

NINDS NIH HHS

Grant: P50 NS072187

NIA NIH HHS

Grant: R01 AG018023

Rainwater Charitable Foundation

CurePSP

FWCI

7.05

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

goldLicense: cc-by

journalhttps://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s13024-024-00747-3

publisherhttps://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s13024-024-00747-3

publisherhttps://link.springer.com/content/pdf/10.1186/s13024-024-00747-3.pdf

publisherhttps://link.springer.com/article/10.1186/s13024-024-00747-3/fulltext.html

journalhttps://doi.org/10.1186/s13024-024-00747-3

Fields of Study

Parkinson's Disease Mechanisms and TreatmentsAlzheimer's disease research and treatmentsGenomics and Rare Diseases

MeSH Terms

Whole Genome SequencingAgedAged, 80 and overFemaleHumansMaleMiddle AgedSupranuclear Palsy, ProgressiveGenetic Predisposition to DiseasePolymorphism, Single NucleotideGenome-Wide Association Study

Keywords

Progressive supranuclear palsyHaplotypeIndelGeneticsBiologyGenetic associationSingle-nucleotide polymorphismStructural variationCopy-number variationAlleleGenome-wide association studyGenotypeGeneGenomeAtrophyGenome-wide Association Study (Gwas)Apolipoprotein E (Apoe)Progressive Supranuclear Palsy (Psp)Whole-genome Sequencing (Wgs)Structural Variants (Svs)

Sustainable Development Goals

SDG 0: Good health and well-being